Overview

Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
To assess the effects of nasal corticosteroid treatment on the rate and extent of intranasal absorption of PMI-150 (intranasal ketamine HCl)
Phase:
Phase 1
Details
Lead Sponsor:
Javelin Pharmaceuticals
Treatments:
Ketamine
Mometasone Furoate